bayer india

Name

bayer india

Website

https://bayer.in

Company type

Private

Headcount range

5,001–10,000 employees

Short description

Bayer India is the Indian subsidiary of Bayer AG, employing 10,000+ people across pharmaceutical, consumer health, and crop science products for Indian patients, consumers, and farmers.

Ownership category

akta.pro rank

Product category

Pharmaceuticals and Healthcare Products

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Pharmaceutical products
• Consumer healthcare
• Crop science solutions
• Medical devices
• Life sciences

Headquarters

HQ city

Thane

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Core offering

Bayer India is the Indian subsidiary of Bayer AG, operating as a life sciences company that manufactures and markets pharmaceutical products, consumer health products, and medical products. The company serves healthcare and nutrition markets with prescription medicines, over-the-counter consumer health offerings, and medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Products Prescription pharmaceutical products developed and marketed by Bayer for therapeutic use across multiple disease areas; primarily for healthcare professionals, hospitals, and patients via prescription in India.
• Consumer Health Products Over-the-counter consumer health products marketed to individual consumers for self-care, wellness, and nutrition needs in India.
• Medical Products Medical devices and related medical products offered to healthcare providers and institutions in India for diagnostic and treatment applications.

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Sun Pharmaceutical Industries: India's largest pharma company with a broad branded generics, specialty, and consumer health portfolio directly overlapping Bayer India's therapeutic and OTC categories in the Indian market.
• Lupin: Leading Indian pharma with a multi-therapy branded portfolio and a growing complex generics/specialty pipeline; competes with Bayer India across chronic and acute therapy areas in India.
• Glenmark Pharmaceuticals: India-focused pharma with branded formulations and specialty innovation; competes in similar therapeutic categories and OTC consumer health adjacencies as Bayer India.
• Novartis India: Indian subsidiary of Novartis operating in patented pharma and branded specialty, mirroring Bayer India's multinational pharma model and competing for the same specialist prescriber channel.
• Cipla: Major Indian pharma with a diversified branded and OTC portfolio across respiratory, cardiology, and consumer health — competing head-to-head with Bayer India across prescription and consumer health segments.
• Abbott India: Indian subsidiary of Abbott operating in branded pharma, consumer health, and nutrition — a direct structural and portfolio peer to Bayer India across multiple healthcare categories.
• Sanofi India: Indian arm of Sanofi with both pharma and consumer health (OTC) portfolios — directly comparable to Bayer India's diversified pharma + consumer health structure in India.
• Dr. Reddy's Laboratories: Indian pharma major with a strong branded portfolio in India plus global generics; directly comparable to Bayer India's branded pharma business and competes for the same prescriber relationships.
• Pfizer India: Indian subsidiary of Pfizer — a multinational pharma with a similar structure to Bayer India, competing in patented and branded prescription pharma across the same prescriber base.

Emerging players

• Biocon: Indian biopharmaceutical company focused on biologics, biosimilars, and specialty pharma; partial overlap with Bayer India's specialty pharma ambitions, particularly as biosimilars gain traction in India.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bayer india